Genetic polymorphism involved in major depressive disorder: a systemic review and meta-analysis

被引:1
|
作者
Suktas, Areeya [1 ]
Ekalaksananan, Tipaya [1 ]
Aromseree, Sirinart [1 ]
Bumrungthai, Sureewan [2 ]
Songserm, Nopparat [3 ]
Pientong, Chamsai [1 ]
机构
[1] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand
[2] Ubon Ratchathani Univ, Fac Pharmaceut Sci, Ubon Ratchathani, Thailand
[3] Ubon Ratchathani Rajabhat Univ, Fac Publ Hlth, Ubon Ratchathani, Thailand
关键词
Single nucleotide polymorphism; BDNF; Major depressive disorder; SEROTONIN TRANSPORTER GENE; SUBSTANCE USE; MESSENGER-RNA; ASSOCIATION; SLC6A4; RISK; BDNF; EXPRESSION; VARIANTS; TRAFFICKING;
D O I
10.1186/s12888-024-06195-z
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background and objectiveGenetic polymorphism studies in families and twins indicated the heritability of depression. However, the association between genes with genetic polymorphism and depression provides various findings and remains unclear. Therefore, we conducted a systematic review and meta-analysis to determine the genes with their polymorphism associated with the symptomatic depression known as major depressive disorder (MDD).Materials and methodsPubMed and Scopus were searched for relevant studies published before May 22, 2023 (1968-2023), and 62 were selected for this review. The study's bias risk was investigated using the Newcastle-Ottawa scale. Gene functional enrichment analysis was investigated for molecular function (MF) and biological process (BP) and pathways. A meta-analysis of the studied genes that were replicative in the same single nucleotide polymorphism was conducted using a random-effect model.ResultsThe 49 genes involved in MDD were studied and engaged in several pathways, such as tryptophan metabolism or dopaminergic and serotonergic synapses. Based on gene overlapping in MF and BP, 13 genes with polymorphisms were identified as related to MDD. Most of them were only studied once. Solute carrier family 6 member 4 (SLC6A4) overlapping between MF and BP and brain-derived neurotrophic factor (BDNF) as unique to BP were replicative studied and used in the meta-analysis. The polymorphism of SLC6A4 SS and LS genotypes increased the occurrence of MDD development but not significantly [odd ratio (OR) = 1.39; 95% confidence interval (CI) = 0.87-2.22; P = 0.16 and OR = 1.13; 95% CI = 0.84-1.53; P = 0.42, respectively]. A similar result was observed for BDNF rs6265 GG (OR = 1.26; 95% CI = 0.78-2.06; P = 0.35) and BDNF rs6265 AA genotypes (OR = 1.12; 95% CI = 0.77-1.64; P = 0.56). These studies indicated low bias and significant heterogeneity.ConclusionAt least 13 studied genes with polymorphisms were involved in MDD development according to MF and BP, but not significantly. These results suggest that MDD development risk factors might require genetic and other factors for interaction and induction.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Meta-analysis of genetic studies in major depressive disorder
    Cecile, A.
    Janssens, J. W.
    Leon, Sandra Lopez
    Ladd, Angela M. Gonzalez-Zuloeta
    Del-Favero, Jurgen
    Claes, Stephan
    Oostra, Ben A.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2006, 141B (07) : 693 - 693
  • [2] Adjunctive cariprazine for major depressive disorder: a systematic review and meta-analysis
    Gill, Hartej
    Chen-Li, David C. J.
    Haikazian, Sipan
    Seyedin, Sam
    McIntyre, Roger S.
    Mansur, Rodrigo B.
    DiVincenzo, Joshua D.
    Phan, Lee
    Rosenblat, Joshua D.
    CNS SPECTRUMS, 2024, 29 (04) : 233 - 242
  • [3] Effectiveness of yoga for major depressive disorder: A systematic review and meta-analysis
    Wu, Yufei
    Yan, Danni
    Yang, Jianli
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [4] Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis
    Kennis, Mitzy
    Gerritsen, Lotte
    van Dalen, Marije
    Williams, Alishia
    Cuijpers, Pim
    Bockting, Claudi
    MOLECULAR PSYCHIATRY, 2020, 25 (02) : 321 - 338
  • [5] Epidemiology of Major Depressive Disorder in Iran: A Systematic Review and Meta-Analysis
    Sadeghirad, Behnam
    Haghdoost, Ali-Akbar
    Amin-Esmaeili, Masoumeh
    Ananloo, Esmaeil Shahsavand
    Ghaeli, Padideh
    Rahimi-Movaghar, Afarin
    Talebian, Elham
    Pourkhandani, Ali
    Noorbala, Ahmad Ali
    Barooti, Esmat
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2010, 1 (02) : 81 - 91
  • [6] Comorbid Major Depressive Disorder in Schizophrenia: A Systematic Review and Meta-Analysis
    Etchecopar-Etchart, Damien
    Korchia, Theo
    Loundou, Anderson
    Llorca, Pierre-Michel
    Auquier, Pascal
    Lancon, Christophe
    Boyer, Laurent
    Fond, Guillaume
    SCHIZOPHRENIA BULLETIN, 2021, 47 (02) : 298 - 308
  • [7] Zuranolone for treatment of major depressive disorder: a systematic review and meta-analysis
    Ahmad, Abdullah
    Awan, Abdul Rafeh
    Nadeem, Natasha
    Javed, Aamir Shahid
    Farooqi, Mobeen
    Daniyal, Muhammed
    Mumtaz, Hassan
    FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [8] Gut microbiota and major depressive disorder: A systematic review and meta-analysis
    Sanada, Kenji
    Nakajima, Shinichiro
    Kurokawa, Shunya
    Barcelo-Soler, Alberto
    Ikuse, Daisuke
    Hirata, Akihito
    Yoshizawa, Akira
    Tomizawa, Yoshihiro
    Salas-Valero, Montserrat
    Noda, Yoshihiro
    Mimura, Masaru
    Iwanami, Akira
    Kishimoto, Taishiro
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 266 : 1 - 13
  • [9] Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
    M Kato
    A Serretti
    Molecular Psychiatry, 2010, 15 : 473 - 500
  • [10] Cortical thickness in major depressive disorder: A systematic review and meta-analysis
    Suh, Jee Su
    Schneider, Maiko Abel
    Minuzzi, Luciano
    MacQueen, Glenda M.
    Strother, Stephen C.
    Kennedy, Sidney H.
    Frey, Benicio N.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2019, 88 : 287 - 302